Post job

Orexigen Therapeutics's revenue is $33.7 million.

What is Orexigen Therapeutics's revenue?

Orexigen Therapeutics's annual revenue is $33.7M. Zippia's data science team found the following key financial metrics about Orexigen Therapeutics after extensive research and analysis.
  • Orexigen Therapeutics has 132 employees, and the revenue per employee ratio is $255,371.
  • Orexigen Therapeutics peak revenue was $33.7M in 2024.

On this page

Peak revenue
$33.7M (2024)
Company peak revenue
Revenue / employee
$255,371
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$33.7M (2024)
Company peak revenue
Revenue / employee
$255,371
Company revenue / employee

Orexigen Therapeutics financing

Orexigen Therapeutics received early financing of $11.0M on 2004-01-22.

SeriesRound sizeDate
Series A$11M01/2004
Series B$35M04/2005
Series C$30M11/2006
Post Ipo Equity$60M09/2015
Post Ipo Equity$165M03/2016

Orexigen Therapeutics investors

InvestorsSecurity type
SOFINNOVA INVESTMENTS INCSeries A
Kleiner PerkinsSeries A
Domain AssociatesSeries A
Scale Venture PartnersSeries B
Morgenthaler VenturesSeries B
Kleiner PerkinsSeries B
Greenspring AssociatesSeries B
Domain AssociatesSeries B
Duke UniversitySeries B
Montreux Equity PartnersSeries B
MPM CapitalSeries C
WASATCH ADVISORS INCSeries C
Baupost GroupPost Ipo Equity

Orexigen Therapeutics competitors

Orexigen Therapeutics's top competitor, Gilead Sciences, earned an annual revenue of $28.8B.

Orexigen Therapeutics's smallest competitor is Intellia Therapeutics with revenue of $57.9M last year.

Orexigen Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Orexigen Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Orexigen Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Orexigen Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Orexigen Therapeutics. The data presented on this page does not represent the view of Orexigen Therapeutics and its employees or that of Zippia.

Orexigen Therapeutics may also be known as or be related to Orexigen Therapeutics, Orexigen Therapeutics Inc, Orexigen Therapeutics Inc. and Orexigen Therapeutics, Inc.